| scholarly article | Q13442814 |
| P50 | author | Jason Brandt | Q43079703 |
| P2093 | author name string | Harris GJ | |
| Bedi A | |||
| Lewis RF | |||
| Schmidt E | |||
| Codori AM | |||
| P2860 | cites work | Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease | Q45296983 |
| Positron emission tomography in the early diagnosis of Huntington's disease | Q45297664 | ||
| PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline | Q45297931 | ||
| Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease | Q45298088 | ||
| Normal caudate glucose metabolism in persons at risk for Huntington's disease | Q45298212 | ||
| The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease | Q45298502 | ||
| Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function | Q45299001 | ||
| Diagnostic value of CT in patients with Huntington's chorea and their offspring | Q45303963 | ||
| Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan | Q45304491 | ||
| Computed Tomographic, Neurologic, and Neuropsychological Correlates of Huntington'S Disease | Q45304617 | ||
| Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease | Q45305415 | ||
| MRI-guided region of interest placement on emission computed tomograms | Q48306253 | ||
| Laboratory Guidelines for Huntington Disease Genetic Testing | Q57629033 | ||
| “Mini-mental state” | Q25938989 | ||
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 | ||
| Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. | Q33592003 | ||
| Neuronal distribution in the putamen in Huntington's disease | Q33621030 | ||
| Neuropsychological and neuroradiological correlates in Huntington's disease | Q33630738 | ||
| Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy | Q39867392 | ||
| A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease | Q41175762 | ||
| Cortical glucose metabolism in Huntington's disease | Q45111537 | ||
| Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease | Q45289936 | ||
| Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. | Q45290072 | ||
| Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease | Q45290976 | ||
| Trial of d-alpha-tocopherol in Huntington's disease | Q45291405 | ||
| Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. | Q45291612 | ||
| Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease | Q45291881 | ||
| Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease | Q45291899 | ||
| Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases | Q45292929 | ||
| Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease | Q45293368 | ||
| Basal ganglia volume and proximity to onset in presymptomatic Huntington disease | Q45293561 | ||
| Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. | Q45294680 | ||
| Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study | Q45295565 | ||
| Brain atrophy in Huntington's disease. A CT-scan study | Q45295633 | ||
| Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease | Q45295880 | ||
| Atrophy of corpus striatum in normal male at risk of Huntington's chorea | Q45296618 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 1667-1678 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease | |
| P478 | volume | 122 ( Pt 9) |
| Q33908988 | A structural MRI study of human brain development from birth to 2 years. |
| Q45305568 | Aberrant astrocytes impair vascular reactivity in Huntington disease |
| Q34917383 | Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease |
| Q39298090 | Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration |
| Q40008936 | Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease |
| Q45305215 | Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology |
| Q37949813 | Cerebrovascular disorders: molecular insights and therapeutic opportunities |
| Q36480706 | Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease. |
| Q37207535 | Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease. |
| Q36711087 | Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis |
| Q33861321 | Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study |
| Q36941187 | Detection of Huntington's disease decades before diagnosis: the Predict-HD study |
| Q33907629 | Development of biomarkers for Huntington's disease |
| Q44517166 | Difficulty modifying a sustained motor response in prodromal Huntington's disease |
| Q37179508 | Diffusion weighted imaging of prefrontal cortex in prodromal Huntington's disease. |
| Q45292699 | Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease |
| Q35037327 | Early atrophy of pallidum and accumbens nucleus in Huntington's disease |
| Q37580232 | Early defect of transforming growth factor β1 formation in Huntington's disease. |
| Q37325474 | Elevated arteriolar cerebral blood volume in prodromal Huntington's disease |
| Q88805262 | Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease |
| Q33405399 | Genetic modulation of striatal volume by loci on Chrs 6 and 17 in BXD recombinant inbred mice |
| Q40154686 | Heritability and genome-wide associations studies of cerebral blood flow in the general population |
| Q36685619 | History of Neural Stem Cell Research and Its Clinical Application |
| Q35918287 | Human neural stem cells genetically modified for brain repair in neurological disorders |
| Q45288836 | Implicit contextual learning in prodromal and early stage Huntington's disease patients. |
| Q35954594 | Language deficits in pre-symptomatic Huntington's disease: evidence from Hungarian. |
| Q41842696 | Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration |
| Q30660816 | Magnetic resonance imaging and magnetic resonance spectroscopy in dementias |
| Q33437923 | Magnetic resonance imaging of Huntington's disease: preparing for clinical trials |
| Q35262146 | Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease |
| Q45303170 | Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease |
| Q33743709 | Motor-Language Coupling in Huntington's Disease Families |
| Q38079295 | Neural stem cell-based treatment for neurodegenerative diseases |
| Q34474382 | Neurocognitive signs in prodromal Huntington disease |
| Q36314026 | Neuroimaging and human genetics |
| Q29615839 | Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders |
| Q38395042 | Non-Verbal and Verbal Fluency in Prodromal Huntington's Disease |
| Q64912813 | Novel targets for Huntington's disease: future prospects. |
| Q36900689 | Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression |
| Q38385717 | Progress in Huntington's disease: the search for markers of disease onset and progression |
| Q35487438 | Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. |
| Q38191477 | Prospects for neuroprotective therapies in prodromal Huntington's disease |
| Q36902073 | Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease. |
| Q45304803 | Reduced striato-cortical and inhibitory transcallosal connectivity in the motor circuit of Huntington's disease patients. |
| Q41169433 | Scanning Patterns of Faces do not Explain Impaired Emotion Recognition in Huntington Disease: Evidence for a High Level Mechanism |
| Q33606063 | Seeking brain biomarkers for preventive therapy in Huntington disease. |
| Q36510210 | Seminar on choreas |
| Q45305995 | Sensation of effort is altered in Huntington's disease |
| Q30485428 | Striatal degeneration impairs language learning: evidence from Huntington's disease. |
| Q36269123 | Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease |
| Q35612769 | Striatal volume contributes to the prediction of onset of Huntington disease in incident cases |
| Q36025447 | Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model |
| Q38663086 | The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers |
| Q36462035 | The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction |
| Q35479486 | Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. |
| Q45305904 | fMRI detection of early neural dysfunction in preclinical Huntington's disease |
Search more.